Early 18F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Nom du journal : J Nucl Med

Année : 2019

Volume : doi: 10.2967/jnumed.119.232827 [Epub ahead of print]

Auteurs: Chauchet A, Touati M, Nicolas-Virelizier E, Moles-Moreau MP, Houot R, Ghesquières H, Casasnovas O, Schmitt A, Bouabdallah K, Morschhauser F, Delmer A, Peyrade F, Borel C, Stamatoullas A, Chen A, Mokrane FZ, Schwartz L, Schiano de Colella JM, Vercellino L, Dulery R, Deau-Fischer B, Seban RD, Manson G, Armand P, Dercle L,